🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction NCT07132190Phase 21 site📍 Boston Ayal A. Aizer, MD · Tests: Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases NCT06401824Phase 23 sites📍 Amsterdam📍 Groningen📍 Maastricht Maastricht University Medical Center · Tests: Sacituzumab Govitecan-Hziy 180 MG plus bevacizumab Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial NCT06974370Phase 21 site📍 Burlington University of Vermont Medical Center · Tests: Active Surveillance Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer NCT05522660Phase 315 sites📍 Naples📍 Padova📍 Perugia ETOP IBCSG Partners Foundation · Tests: Stereotactic radiosurgery, Immune checkpoint inhibitor Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer NCT05800223Phase 31 site📍 Shanghai Shanghai Cancer Hospital, China · Tests: Almonertinib, SBRT A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871Phase 153 sites📍 La Jolla📍 Los Angeles📍 Aurora Iambic Therapeutics, Inc · Tests: IAM1363 SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET) NCT05689619NA6 sites📍 Genova📍 Messina📍 Rome A.O.U. Città della Salute e della Scienza · Tests: Silibinin, Placebo Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases NCT06702826Phase 21 site📍 Changsha Rongrong Zhou · Tests: Cadonilimab combined with SRS BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies NCT07789912NA1 site📍 Miami University of Miami · Tests: Radiation Treatments Using Brain- Avoidant Proton Craniospinal Irradiation (BRAVO- pCSI) SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer NCT06476093NA1 site📍 Lianyungang The First People's Hospital of Lianyungang · Tests: Anlotinib hydrochloride Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases NCT07511933NA1 site📍 Amsterdam The Netherlands Cancer Institute · Tests: 86-Gallium PSMA PET/CT Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases NCT07130786Phase 21 site📍 Boston Ayal A. Aizer, MD · Tests: Levetiracetam (Keppra) A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer) NCT06822543Phase 213 sites📍 Fortaleza📍 Salvador📍 Belo Horizonte Latin American Cooperative Oncology Group · Tests: Pembrolizumab, Datopotamab deruxtecan, Carboplatin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy